Nanostics and Alberta Health Services collaborate to develop new diagnostic...
EDMONTON, ALBERTA – April 9th – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, is excited to announce a partnership with Cancer Care...
View ArticleProstate Cancer Screening in 2024
Dr. Chris Wallis talks about the benefits and harms of prostate cancer screening in 2024 using PSA and the addition of adjunctive tests like ClarityDX Prostate. Source
View ArticleNanostics Receives Funding from the University of Alberta Innovation Fund to...
EDMONTON, ALBERTA – April 23 – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today that it received an investment from the...
View ArticleNanostics partners with CDL Laboratories to Provide Access to ClarityDX...
EDMONTON, ALBERTA – May 22 – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, signed an agreement with Quebec-based CDL Laboratories (CDL)...
View ArticleNanostics Prostate Cancer Screening Test, ClarityDX Prostate®, becomes...
EDMONTON, AB, June 5, 2024 /CNW/ – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, is thrilled to announce today that men can now provide...
View ArticleNanostics and Protean Launch CDX Prostate for Men at Risk of Having...
EDMONTON, Alberta–Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, and Protean Biodiagnostics Inc. (Protean) today announced their...
View ArticleNanostics and OncoHelix Partner to Provide ClarityDX Prostate for Men at Risk...
EDMONTON, Alberta & CALGARY, Alberta–Nanostics. Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, and OncoHelix a leader in precision...
View ArticleNanostics and Protean BioDiagnostics Announce American Medical Association...
EDMONTON, Alberta – ORLANDO, Florida – February 12 – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX platform technology, and Protean BioDiagnostics Inc....
View ArticleNanostics Launches Clinical Utility Study for Its AI-Powered ClarityDX...
EDMONTON, AB, April 23, 2025 – Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, has met a major milestone with the recruitment of the...
View ArticleMajor Investment from Genome Canada to Help Advance ClarityDX Prostate...
Funding to Propel Widespread Adoption and Integration of Innovative Prostate Cancer Diagnostic Test into Canadian Healthcare EDMONTON, AB, June 26, 2025 – Nanostics Inc., a precision health company...
View Article